nejm semaglutide heart failure 📌 Most viewed this week from JAMA: In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for or all-cause mortality vs sitagliptin, but tirzepatide offered no obesity #clinicaltrials #medicalresearch | NEJM

Platelet mitochondria, a potent immune mediator in neurological diseases

Review sections that highlight bonus terms, wagering requirements, and eligible games ensure there are no surprises down the road

Effective Sample Size Estimation The effective sample size was calculated using the following formula: Effective sample size = N (1 annual loss to follow-up) total years , where N is the number of participants, and total years indicate the trial duration

ED that shows up consistently, however, deserves a workup, because the right next step depends on the cause

Finding: 14% reduction in major adverse cardiovascular events (MACE) with oral semaglutide

This can result in the characteristic burning sensation and discomfort associated with acid reflux